Joel Lewis, President and CEO at GALECTIN THERAPEUTICS INC (GALT), sold 168,000 shares at $4.20 ($643K) on 2026-01-02, disclosed to the SEC on 2026-01-06.
Seasonal sale ($643k) by President and CEO — this insider has traded GALT in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.20 | 18,571 | $78K | 12.1% |
| 2 | $4.20 | 18,571 | $78K | 12.1% |
| 3 | $3.91 | 27,731 | $108K | 16.9% |
| 4 | $3.91 | 27,731 | $108K | 16.9% |
| 5 | $3.58 | 37,698 | $135K | 21.0% |
| 6 | $3.58 | 37,698 |
| $135K |
| 21.0% |
| Total | $3.82 avg | 168,000 | $643K | 100% |
| Filing → |
| GALT | SELL | 2025-11-12 | $11K | — | Filing → |
| GALT | SELL | 2025-11-07 | $1K | — | Filing → |
| GALT | SELL | 2025-11-05 | $183K | — | Filing → |